Anti-RGMB/ DRAGON monoclonal antibody

Anti-RGMB/ DRAGON antibody for FACS & in-vivo assay

Target products collectionGo to RGMB/RGMB products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1460-Ab-1/ GM-Tg-hg-MP1460-Ab-2Anti-Human RGMB monoclonal antibodyHuman
GM-Tg-rg-MP1460-Ab-1/ GM-Tg-rg-MP1460-Ab-2Anti-Rat RGMB monoclonal antibodyRat
GM-Tg-mg-MP1460-Ab-1/ GM-Tg-mg-MP1460-Ab-2Anti-Mouse RGMB monoclonal antibodyMouse
GM-Tg-cynog-MP1460-Ab-1/ GM-Tg-cynog-MP1460-Ab-2Anti-Cynomolgus/ Rhesus macaque RGMB monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1460-Ab-1/ GM-Tg-felg-MP1460-Ab-2Anti-Feline RGMB monoclonal antibodyFeline
GM-Tg-cang-MP1460-Ab-1/ GM-Tg-cang-MP1460-Ab-2Anti-Canine RGMB monoclonal antibodyCanine
GM-Tg-bovg-MP1460-Ab-1/ GM-Tg-bovg-MP1460-Ab-2Anti-Bovine RGMB monoclonal antibodyBovine
GM-Tg-equg-MP1460-Ab-1/ GM-Tg-equg-MP1460-Ab-2Anti-Equine RGMB monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1460-Ab-1/ GM-Tg-hg-MP1460-Ab-2; GM-Tg-rg-MP1460-Ab-1/ GM-Tg-rg-MP1460-Ab-2;
GM-Tg-mg-MP1460-Ab-1/ GM-Tg-mg-MP1460-Ab-2; GM-Tg-cynog-MP1460-Ab-1/ GM-Tg-cynog-MP1460-Ab-2;
GM-Tg-felg-MP1460-Ab-1/ GM-Tg-felg-MP1460-Ab-2; GM-Tg-cang-MP1460-Ab-1/ GM-Tg-cang-MP1460-Ab-2;
GM-Tg-bovg-MP1460-Ab-1/ GM-Tg-bovg-MP1460-Ab-2; GM-Tg-equg-MP1460-Ab-1/ GM-Tg-equg-MP1460-Ab-2
Products NameAnti-RGMB monoclonal antibody
Formatmab
Target NameRGMB
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-RGMB benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species RGMB/ DRAGON VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLPm002101mouse Rgmb Lentivirus plasmid
    ORF Viral VectorvGMLPm002101mouse Rgmb Lentivirus particle


    Target information

    Target IDGM-MP1460
    Target NameRGMB
    Gene ID285704,68799,681433,701700,479146,101089491,540954,100073220
    Gene Symbol and Synonyms1110059F19Rik,DRAGON,RGMB
    Uniprot AccessionQ6NW40
    Uniprot Entry NameRGMB_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000174136
    Target ClassificationN/A

    The target: RGMB, gene name: RGMB, also named as DRAGON. RGMB is a glycosylphosphatidylinositol (GPI)-anchored member of the repulsive guidance molecule family (see RGMA, MIM 607362) and contributes to the patterning of the developing nervous system (Samad et al., 2005 [PubMed 15671031]).[supplied by OMIM, Apr 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.